Department of Orthopedics and Traumatology, Ege University, Talatpasa Bulvari, Sezik Apt., No: 61/3 Alsancak, Izmir, Turkey.
J Orthop Traumatol. 2019 Apr 16;20(1):22. doi: 10.1186/s10195-019-0527-1.
Critical-sized bone defects of the tibia are complex injuries associated with significant problems that are difficult to treat, and they are associated with a significant burden of disease in clinical practice; however, the treatment of these cases has still been a challenge for orthopedic surgeons. The aim of this review was to evaluate the current available studies reporting on classical Ilizarov methods in the treatment of infected or noninfected critical-sized bone defects of the tibia, and to perform an analysis of treatment period and complications.
This is a narrative review based on a comprehensive literature search among the studies in Pubmed, Scopus and Web of Science articles. The studies included were written in the English language or translated to English and they were published between 2008 and 2018. They were appraised with narrative data synthesis. The primary outcome measures were the external fixation time (EFT), bone union rate, and bone and functional results. Secondary outcomes were complications including docking site problems and solutions. The heterogeneity of the data in the studies which were taken into consideration allowed a narrative analysis.
Twenty-seven articles with 619 patients were included in this study. These included 6 prospective and 21 retrospective case series. Mean age was 36.1 (range 13-89) years. Of the cases, 88.8% were infected and the remaining 11.2% were noninfected. The external fixation time was 10.75 (range 2.5-23.2) months. The mean bone union rate was 90.2% (range 77-100)%. Radiographic outcome measures were reported in 20 studies. Functional outcome measures were reported in 18 studies. ASAMI (Association for the Study of the Method of Ilizarov) criteria are useful and give reproducible data on patient outcome measurements. Data collected from these studies showed excellent radiological outcomes in 303, good in 143, fair in 31, and poor in 25 patients. Functional outcomes were excellent in 200, good in 167, fair in 58, and poor in 19, where reported. The excellent and good rate in bone results and functional results were 88.8% and 82.6%, respectively. The poor rate in bone results and functional results were 5% and 4.5%. Mean complication rate per patient was 1.22 (range 3-60). The most common complication was pin tract infection (PTI). Its occurrence was 46.6%. Joint stiffness followed PTI with a 25% incidence. The rates of refracture, malunion, infectious recurrence, and amputation, were 4%, 8.4%, 4.58%, and 1%, respectively.
This narrative review shows that the patients with infected or noninfected critical-sized tibial bone defects treated by Ilizarov methods had a low rate of poor bone and functional results. Therefore, Ilizarov methods may be a good choice for the treatment of infected or noninfected tibial bone defects. The small number of cases in some studies, the absence of homogenity between studies and the fact that most data available are derived from retrospective studies are some of the difficulties encountered in the evaluation of evidence.
V.
胫骨临界尺寸骨缺损是一种复杂的损伤,伴有严重的问题,难以治疗,在临床实践中存在着很大的疾病负担;然而,这些病例的治疗仍然是骨科医生面临的挑战。本综述的目的是评估目前关于经典伊里扎洛夫(Ilizarov)方法治疗感染或非感染胫骨临界尺寸骨缺损的现有研究,并对治疗期和并发症进行分析。
这是一项基于 Pubmed、Scopus 和 Web of Science 文章中全面文献检索的叙述性综述。纳入的研究为英文或翻译成英文的研究,并于 2008 年至 2018 年发表。使用叙述性数据综合评估这些研究。主要结局指标是外固定时间(EFT)、骨愈合率以及骨和功能结果。次要结局指标包括固定钉道问题及解决方案。考虑到纳入研究的数据异质性,允许进行叙述性分析。
这项研究纳入了 27 篇文章,共 619 例患者,其中包括 6 项前瞻性和 21 项回顾性病例系列研究。平均年龄为 36.1(13-89)岁。其中 88.8%的病例为感染,其余 11.2%为非感染。外固定时间为 10.75(2.5-23.2)个月。平均骨愈合率为 90.2%(77-100)%。20 项研究报告了影像学结果测量,18 项研究报告了功能结果测量。ASAMI(Ilizarov 方法研究协会)标准是有用的,可以提供患者结果测量的可重复数据。从这些研究中收集的数据显示,303 例患者的影像学结果优秀,143 例良好,31 例一般,25 例较差。200 例患者功能结果优秀,167 例良好,58 例一般,19 例较差。骨结果和功能结果的优秀和良好率分别为 88.8%和 82.6%。骨结果和功能结果的较差率分别为 5%和 4.5%。每位患者的平均并发症发生率为 1.22(3-60)。最常见的并发症是固定钉道感染(PTI),发生率为 46.6%。紧随 PTI 之后的是关节僵硬,发生率为 25%。再骨折、畸形愈合、感染复发和截肢的发生率分别为 4%、8.4%、4.58%和 1%。
这项叙述性综述表明,采用伊里扎洛夫(Ilizarov)方法治疗感染或非感染胫骨临界尺寸骨缺损的患者,其骨和功能结果较差的比例较低。因此,伊里扎洛夫(Ilizarov)方法可能是治疗感染或非感染胫骨骨缺损的一种较好选择。一些研究中病例数量较少,研究之间缺乏同质性,以及大多数现有数据来自回顾性研究,这些都是评估证据时遇到的一些困难。
V。